ArticleOncotarget2018

2'-deoxy-2'-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neck.

Lionel Mignion et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.